Yield10 Bioscience, Inc. (YTEN)
OTCMKTS: YTEN · Delayed Price · USD
1.680
+0.070 (4.35%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Company Description
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.
Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF).
The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.
Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Yield10 Bioscience, Inc.
| Country | United States |
| Founded | 1992 |
| IPO Date | Nov 10, 2006 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 29 |
| CEO | Dr. Oliver P. Peoples Ph.D. |
Contact Details
Address: 19 Presidential Way, Suite 201 Woburn, Massachusetts 01801 United States | |
| Phone | 617-583-1700 |
| Website | yield10bio.com |
Stock Details
| Ticker Symbol | YTEN |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001121702 |
| CUSIP Number | 98585K862 |
| ISIN Number | US98585K8624 |
| Employer ID | 04-3158289 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Dr. Oliver P. Peoples Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
| Dr. Anthony J. Sinskey Ph.D., Sc.D. | Co-Founder and Independent Director |
| Dr. Kristi D. Snell | Vice President of Research and Chief Science Officer |
| Lynne H. Brum | Vice President of Planning and Corporate Communications and Secretary |
| Charles B. Haaser | Vice President of Finance, Chief Accounting Officer and Treasurer |
| Dr. Nicholas Renegar Ph.D. | Director of Business Analytics and Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 19, 2024 | 25-NSE | Filing |
| Jul 17, 2024 | 8-K | Current Report |
| Jun 12, 2024 | 8-K | Current Report |
| Jun 10, 2024 | 8-K | Current Report |
| May 28, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 23, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 15, 2024 | 8-K | Current Report |
| May 15, 2024 | 8-K | Current Report |
| May 9, 2024 | RW | Filing |